Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-089 in adults with ADHD
NCT00391729Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Oct 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing ABT-089 Sequence with Placebo Sequence (2 arms). Primary endpoint: Conners' Adult ADHD Rating Scale Total Score at 4 weeks. Started Oct 2006; status: completed.
02
Drugs
pozanicline
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00391729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391729.